You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 5, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 4, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$608.49
Nov 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000179
Filing cohort
Transactions in this filing
Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.78M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $22.65K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $46.73K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $758.32K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $360.58K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $321.29K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $126.74K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $77.43K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $95.14K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $285.04K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $163.97K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $235.28K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $190.79K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $96.56K |
| United Therapeutics Corp UTHR Current | Exercise | Nov 4, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $109.64K |